SM
CRMD icon

Sabby Management’s CorMedix CRMD Stock Holding History

Sabby Management’s Portfolio CRMD Stock Details CRMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-894
Closed -$664K – 167
2020
Q4 		$664K Buy
894
+785
+720% +$5.34K 0.13% 57
2020
Q3 		$66K Buy
+109
New +$547 0.01% 123
2019
Q4 		– Sell
-1,936
Closed -$1.24M – 77
2019
Q3 		$1.24M Sell
1,936
-2,697
-58% -$22.7K 0.67% 20
2019
Q2 		$2.57M Sell
4,633
-3,118
-40% -$24.5K 3.23% 5
2019
Q1 		$7.33M Buy
7,751
+7,690
+12,607% +$69.3K 3.52% 4
2018
Q4 		$41K Buy
61
+4
+7% +$27 0.01% 98
2018
Q3 		$28K Buy
+57
New +$140 ﹤0.01% 116

Other funds holding CRMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
EIM
Elliott Investment Management West Palm Beach, Florida $22.7B AUM 59.88% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CAM
Cresset Asset Management Chicago, Illinois $27.6B AUM 31.92% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Sabby Management's CRMD Position: Q4 2019 in Review

Sabby Management sold out of CorMedix (CRMD) in Q4 2019, closing a stake of 249,198 shares — an estimated $1.59M sold.

Sabby Management first reported a position in CRMD in Q2 2017 and held it in 5 quarters. The position peaked at $1.82M in Q2 2017. 62 funds tracked by Wall St. Rank hold CRMD as of Q4 2019.

  • Sabby Management reported no remaining CorMedix position as of Q4 2019 after selling out during the quarter.
  • Sabby Management sold 249,198 CorMedix shares in Q4 2019, an estimated $1.59M.
  • Sabby Management first reported a position in CorMedix in Q2 2017 and held it in 5 quarters.
  • Sabby Management's CorMedix position peaked at $1.82M in Q2 2017.
  • 62 funds tracked by Wall St. Rank held CorMedix as of Q4 2019.

Based on Sabby Management's 13F filing for Q4 2019, filed 14 Feb 2020.